Financial Performance - The company's revenue for Q1 2025 was ¥232,487,301.18, a decrease of 33.08% compared to ¥347,417,123.65 in the same period last year[2] - The net profit attributable to shareholders was a loss of ¥89,272,138.46, an improvement from a loss of ¥129,609,219.28 year-over-year[2] - The total operating revenue for Q1 2025 was ¥232.49 million, a decrease of 33% compared to ¥347.42 million in Q1 2024[15] - Net loss for Q1 2025 was ¥89.20 million, an improvement from a net loss of ¥133.84 million in Q1 2024[16] - Operating profit for Q1 2025 was -¥66.92 million, compared to -¥135.68 million in Q1 2024, indicating a reduced loss[16] - The company reported a basic and diluted earnings per share of -¥0.16 for Q1 2025, compared to -¥0.23 in Q1 2024[17] Cash Flow - The net cash flow from operating activities was ¥78,758,320.81, a significant recovery from a negative cash flow of ¥119,365,965.68 in the previous year[2] - Cash flow from operating activities in Q1 2025 was ¥175.09 million, down 31% from ¥255.12 million in Q1 2024[19] - The total cash outflow for operating activities was $142,754,631.03, compared to $383,226,455.30 in the previous year[20] - The cash flow from operating activities showed a positive trend, indicating improved operational efficiency[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,289,978,058.24, a decrease of 2.63% from ¥6,459,726,375.01 at the end of the previous year[3] - The total liabilities decreased to ¥2.65 billion in the latest report from ¥2.73 billion previously, reflecting a reduction of approximately 3%[12] - The equity attributable to shareholders decreased by 2.42% to ¥3,579,004,669.86 from ¥3,667,934,028.94[3] - Total current liabilities of approximately RMB 2.61 billion, with short-term borrowings at RMB 658.13 million[12] Research and Development - Research and development expenses totaled ¥21,011,474.30, down 30.52% from ¥30,239,007.96, while the R&D expense as a percentage of revenue increased to 9.04% from 8.70%[2] - Research and development expenses for Q1 2025 were ¥21.01 million, down 30% from ¥30.24 million in Q1 2024[16] - The company has strengthened its collaboration with Beijing Institute of Technology for research on carbon-based composite materials, achieving significant progress in the production of carbon honeycomb materials[10] Strategic Initiatives - The company aims to enhance operational efficiency and reduce costs, which contributed to a decrease in overall revenue but improved net profit margins[5] - The company has completed multiple batch deliveries for two mass production models for a leading new energy vehicle company, entering the pre-mass production preparation phase[10] - The company has established strategic cooperation with Carbon One Group in the silicon-oxygen negative electrode sector, beginning bulk supply to its subsidiaries[10] - The company achieved its first order in the synthetic diamond industry, with expectations for formal bulk supply in the first half of this year[10] - The company is actively advancing projects in carbon-carbon composite materials, achieving breakthroughs in various industries including magnetic materials and synthetic diamonds[10] Other Financial Metrics - Non-recurring gains and losses amounted to ¥7,240,831.09, primarily from government subsidies and asset disposals[4] - The company’s deferred income increased to ¥85.91 million from ¥61.34 million, a rise of approximately 40%[12] - The company's cash and cash equivalents decreased to RMB 222.55 million from RMB 266.76 million, representing a decline of approximately 16.54%[11] - Accounts receivable increased to RMB 711.08 million, up from RMB 666.36 million, indicating a growth of about 6.69%[11] - Inventory decreased to RMB 368.61 million from RMB 410.52 million, a reduction of approximately 10.21%[11]
天宜上佳(688033) - 2025 Q1 - 季度财报